Huberman Lab
Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity
Andrew Huberman
That, to my understanding, caused a severe setback to the whole field. I'm old enough to remember when gene therapy was set back by about 10 years because a patient received gene therapy, which is now pretty common for certain diseases, and the patient died. It's unclear exactly why they died, but that delayed the field of gene therapy by at least a decade.
0
💬
0
Comments
Log in to comment.
There are no comments yet.